Trisomy 16, an extra copy of chromosome 16, is the single most common chromosomal abnormality found in early pregnancy losses. In its complete form, it is almost always lethal before the end of the first trimester, meaning no baby is born with full trisomy 16. But the story does not end there. A mosaic version of the condition, where only some cells carry the extra chromosome, can allow a pregnancy to continue, and the complications that follow are wide-ranging and sometimes subtle enough to go undetected until after birth.
Why Trisomy 16 Is So Common in Miscarriages
Among pregnancies that end in early miscarriage and are tested for chromosomal problems, trisomy 16 stands out. In one analysis of 900 samples from early pregnancy losses, trisomy 16 accounted for about 27% of all trisomy cases, making it more common than the next three combined: trisomy 22, trisomy 21, and trisomy 15.1PubMed Central. Chromosomal Abnormalities in Early Pregnancy Losses: A Study of 900 Samples That frequency is striking given that most people have only heard of trisomy 21 (Down syndrome) or trisomy 18 (Edwards syndrome). Full trisomy 16 almost never makes it past about 12 to 15 weeks of gestation. The embryo simply cannot develop normally with three copies of such a gene-rich chromosome.
The reason trisomy 16 appears so often comes down to how egg cells divide. Studies tracing the parental origin of the extra chromosome have consistently found that virtually all cases stem from an error during the mother’s first round of meiotic cell division.2PubMed. Origin and mechanisms of non-disjunction in human autosomal trisomies In one study that could pinpoint the origin in 22 cases, every single one was traced to maternal meiosis I, and the remaining four cases were consistent with the same origin.3Journal of Medical Genetics. Molecular studies of non-disjunction in trisomy 16 This pattern is not unique to chromosome 16; errors in maternal meiosis I are the leading cause of most autosomal trisomies, and the risk rises with maternal age. But chromosome 16’s particular size and recombination patterns seem to make it especially vulnerable.
How Mosaic Trisomy 16 Allows Survival
If full trisomy 16 is uniformly lethal, how do some pregnancies with this finding continue? The answer lies in mosaicism. Early in embryonic development, after the trisomic conception has occurred, some cells can spontaneously lose the extra chromosome through a process sometimes called “trisomic rescue.” This leaves a mixture: some cells with the normal two copies of chromosome 16 and others still carrying three. If enough of the embryo’s own cells correct themselves, development can proceed, though usually not without consequences.
There is also a scenario where the trisomy is confined entirely to the placenta while the fetus itself has a normal chromosome count. This is known as confined placental mosaicism, or CPM. When the placenta carries the abnormal cells but the baby does not, you might expect a normal outcome, but that is not what happens. Even when trisomy 16 is restricted to the placenta, it can still cause serious problems by impairing how the placenta functions. Babies in these pregnancies tend to be small, and early delivery is more common than usual.4Genetics in Medicine. Outcome in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA
One observation from preimplantation embryo research adds a curious wrinkle. Embryos with trisomy 16 show reduced growth of the outer cell layer that eventually becomes the placenta, but the inner cells destined to become the embryo itself appear relatively unaffected in early stages.5Human Reproduction Update. Confined placental mosaicism and the association with pregnancy outcome and fetal growth: a review of the literature Some researchers have speculated that an extra chromosome 16 might initially help with implantation, which could partly explain why trisomy 16 conceptions are so common in the first place. That idea is still speculative, but it raises interesting questions about why this particular trisomy outpaces all others.
What Happens When the Placenta Carries Trisomy 16
Confined placental mosaicism involving trisomy 16 is not a benign finding. Among all the chromosomal abnormalities that can be limited to the placenta, trisomy 16 consistently causes the most trouble. One study found that CPM with trisomy 16 was linked to a roughly 11-fold increase in the odds of a baby being born very small for gestational age (below the 3rd percentile) and about a 10-fold increase in the odds of preterm delivery.6Genetics in Medicine. Outcome in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA Low Apgar scores at birth were also significantly more common. Other rare chromosomal abnormalities confined to the placenta did not show the same pattern of growth restriction, making trisomy 16 CPM distinctive in its severity.
The degree of mosaicism matters, too. When researchers looked at how many placental cells carried the trisomy, they found that higher levels of abnormal cells in both layers of the placenta were associated with lower birth weight. But the relationship was modest: the proportion of trisomic cells in the placenta explained only a small fraction of the variation in how much babies weighed, meaning other factors are clearly involved.7Genetics in Medicine. Outcome in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA
Pregnancy Complications and Birth Outcomes
When mosaic trisomy 16 is present in either the placenta or the fetus, pregnancies tend to be complicated. A study reviewing outcomes across a cohort of mosaic trisomy 16 pregnancies found strikingly high rates of problems: about 38% developed gestational hypertension or preeclampsia, roughly 71% delivered preterm, nearly 74% needed cesarean sections, and around 74% of babies weighed below the 10th percentile for their gestational age. Close to 88% of newborns were admitted to the neonatal intensive care unit, and about 60% had at least one congenital anomaly detected.8Genetics in Medicine. Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes?
Those numbers are worth pausing over. Even among high-risk pregnancies, these rates are unusually high. They mean that a mosaic trisomy 16 pregnancy is more the exception than the rule if it proceeds smoothly. For parents and clinicians, the practical takeaway is that these pregnancies require close monitoring, frequent ultrasound assessments, and planning for the likelihood of early delivery and NICU care.
How It Affects the Baby After Birth
The range of birth defects seen in children born with mosaic trisomy 16 is broad. Heart defects are the most commonly reported structural problems, particularly ventricular and atrial septal defects (holes between the heart chambers). Hypospadias, a urinary tract abnormality in boys, is also frequently described. One review of live births with mosaic trisomy 16 found that about 45% had at least one malformation.9Journal of Medical Genetics. Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicism Anomalies of the musculoskeletal system, genitourinary tract, and central nervous system have all been documented.10Genetics in Medicine. Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes?
An underappreciated feature is body asymmetry. In the same cohort study, about 21% of children showed some form of asymmetry, such as unevenly set eyes, ears, or nipples, facial asymmetry, or one limb being slightly shorter than the other.11Genetics in Medicine. Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes? This likely reflects the mosaic nature of the condition: because only some cells carry the extra chromosome, different parts of the body can be affected to different degrees, leading to lopsided development.
When researchers compared children who had trisomy 16 in their own body cells (true mosaicism) to those who had it confined to the placenta, the group with true mosaicism fared worse. About 70% of children with confirmed mosaicism in fetal tissues had at least one congenital anomaly, compared to about 33% of those whose trisomy was confined to the placenta. Musculoskeletal problems showed the starkest divide, appearing in 30% of the mosaicism group and none of the CPM group.12PubMed Central. Mosaic trisomy 16: what are the obstetric and long-term childhood outcomes? Rare case reports have expanded the known spectrum even further, documenting findings like absent lungs and major limb abnormalities in individual patients.13PubMed Central. Mosaic Trisomy 16 Associated with Left Lung Agenesis, Abnormal Left Arm, and Right Pulmonary Artery Stenosis: Expanding the Phenotype and Review of the Literature
The Complication of Uniparental Disomy
Trisomic rescue, the process that can convert a full trisomy 16 conception into a mosaic one, introduces another genetic wrinkle. When the cell randomly discards one of the three copies of chromosome 16, there is a one-in-three chance that both remaining copies will come from the same parent, usually the mother. This is called maternal uniparental disomy of chromosome 16, and it creates its own set of problems.
For years, researchers debated whether the health issues seen in these children were caused by inheriting both chromosome 16s from the mother or by the lingering trisomy 16 cells still hiding in tissues. A careful evaluation of published cases concluded that the clinical features are better explained by hidden trisomy 16 mosaicism rather than by uniparental disomy itself, and that a specific imprinting disorder tied to chromosome 16 probably does not exist.14PubMed. Maternal uniparental disomy of chromosome 16 [upd(16)mat]: clinical features are rather caused by (hidden) trisomy 16 mosaicism than by upd(16)mat itself
That said, the picture is not fully resolved. Other work has found that uniparental disomy seems to independently worsen fetal growth restriction and may increase the risk of major malformations, even after accounting for the degree of trisomy in fetal tissues.15PubMed. Evidence for imprinting on chromosome 16: the effect of uniparental disomy on the outcome of mosaic trisomy 16 pregnancies The hypothesis is that one or more genes on chromosome 16 are imprinted, meaning their function depends on whether the copy came from the mother or the father. Receiving two maternal copies could silence or double the expression of genes that normally need one copy from each parent. In rare individual cases, the clinical picture has been traced to homozygosity for a recessive mutation: when both copies of chromosome 16 come from the mother, and she happens to be a carrier of a recessive condition on that chromosome, the child inherits two defective copies instead of one.16PubMed. Maternal uniparental disomy of chromosome 16 [upd(16)mat]: clinical features are rather caused by (hidden) trisomy 16 mosaicism than by upd(16)mat itself This underscores why genetic testing in these pregnancies can reveal more than one layer of complexity.
Finding Trisomy 16 Before Birth
Trisomy 16 can be discovered through several prenatal testing routes, and each one comes with significant interpretive challenges. Chorionic villus sampling (CVS), which takes a small piece of placental tissue in early pregnancy, was the first method to reveal that trisomy 16 could be confined to the placenta while the fetus appeared chromosomally normal.17Fetal Diagnosis and Therapy. Viable Pregnancies after Diagnosis of Trisomy 16 by CVS: Lethal Aneuploidy Compartmentalized to the Trophoblast If CVS finds trisomy 16 but the pregnancy appears viable on ultrasound, the karyotype is likely coming from the placenta rather than the fetus. Follow-up with amniocentesis, which samples fetal cells, is essential to determine whether the fetus itself is affected.
Cell-free DNA screening, sometimes called NIPT, adds another layer of complication. This blood test analyzes fragments of DNA circulating in the mother’s blood, most of which come from the placenta rather than directly from the fetus. If the placenta carries trisomy 16 mosaicism, the test will flag it. But the positive predictive value of cell-free DNA testing for rare autosomal trisomies like trisomy 16 is low. A systematic review and meta-analysis found a pooled positive predictive value of about 11%, meaning roughly nine out of ten flagged results turn out to be false positives after confirmatory testing.18PubMed. The predictive value of prenatal cell-free DNA testing for rare autosomal trisomies: a systematic review and meta-analysis A smaller case series reported a true positive rate of about 36% for trisomy 16 specifically, though the numbers involved were small.19PubMed Central. Outcomes of pregnancies with trisomy 16 mosaicism detected by NIPT: a series of case reports
The practical upshot for anyone who receives a high-risk NIPT result for trisomy 16: this result cannot be used in isolation to make clinical decisions. It requires diagnostic confirmation through amniocentesis or detailed ultrasound evaluation, and even when confirmed, the prognosis varies enormously depending on whether the trisomy is in the placenta alone, in fetal tissues, or both. Some cell-free DNA results flagging trisomy 16 have ultimately been explained by a co-twin that was lost early in pregnancy rather than by a chromosomal problem in the surviving fetus.20Genetics in Medicine. Systematic evidence-based review: The application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies
Partial Trisomy 16
Distinct from either full or mosaic trisomy 16 is partial trisomy 16, where only a segment of the chromosome is duplicated rather than the whole thing. Because less genetic material is involved, partial trisomy 16 can be compatible with live birth, though outcomes are generally severe. It appears that having an extra copy of just the short arm (16p) or the long arm (16q) can allow some postnatal survival, whereas full trisomy does not.21Journal of Medical Genetics. Trisomy 16p in a liveborn infant and a review of partial and full trisomy 16
Partial trisomy of the long arm, particularly of the segment 16q, is a recognized clinical entity associated with a range of problems including small head size, heart malformations, ambiguous genitalia, distinctive facial features, and profound growth restriction.22PubMed. Karyotype/phenotype correlation in partial trisomies of the long arm of chromosome 16: case report and review of literature It remains extremely rare: only a handful of cases have ever been reported with specific long-arm duplications, and most of those children died in infancy. Because so few cases exist, researchers have not yet been able to map out which specific gene regions drive which features, though a critical region spanning the middle of the long arm has been proposed.23PubMed Central. A rare description of pure partial trisomy of 16q12.2q24.3 and review of the literature
What Trisomy 16 Does at the Molecular Level in the Placenta
Recent research has started to uncover why trisomy 16 disrupts placental function so severely. An analysis comparing DNA methylation patterns in first-trimester placentas from trisomy 16 miscarriages with those from other aneuploidies identified 97 sites across 91 genes where methylation was significantly altered. Many of these genes encode secreted proteins, signaling molecules, and receptors, the kinds of molecules the placenta uses to communicate with the mother’s body and regulate its own growth. Notably, these methylation changes were specific to trisomy 16 and did not appear in miscarriages caused by other chromosomal abnormalities.24Nature / Scientific Reports. Identification of differentially methylated genes in first-trimester placentas with trisomy 16
This finding suggests that the extra chromosome 16 does not simply overwhelm cells with too much genetic material in a generic way. Instead, it appears to disrupt specific regulatory pathways in the placenta, which may help explain why trisomy 16 placental mosaicism causes such pronounced growth restriction even when the fetus itself has a normal karyotype. The research is still early, and none of the identified genes have been definitively linked to the clinical features yet, but the specificity of the methylation pattern points toward targeted molecular mechanisms rather than simple chromosomal overload.
Trisomy 16 as a Model in Mouse Research
Chromosome 16 in mice shares significant genetic content with human chromosome 21, and for decades the mouse with trisomy 16 was used as a model for studying Down syndrome in humans.25PubMed. Cardiac morphology at late fetal stages in the mouse with trisomy 16: consequences for different formation of the atrioventricular junction when compared to humans with trisomy 21 This can cause some confusion, because mouse trisomy 16 and human trisomy 16 are fundamentally different conditions. The mouse version is used to study human trisomy 21, not human trisomy 16. The shared gene content between human chromosome 21 and mouse chromosome 16 made this a useful, if imperfect, animal model, particularly for studying heart defects associated with Down syndrome. Newer mouse models carrying only the specific gene segments shared with human chromosome 21 have largely replaced the full trisomy 16 mouse, but the historical use of this model means that a literature search for “trisomy 16” can sometimes return results that are actually about Down syndrome research rather than the human condition this article addresses.